New drug duo tested in battle against spreading prostate cancer
NCT ID NCT02522715
Summary
This study is testing the safety and effectiveness of combining two drugs, enzalutamide and cabazitaxel, for men with advanced prostate cancer that has spread and is no longer responding to standard hormone treatments. The goal is to see if using these drugs together can better control the cancer and reduce PSA levels. The trial will also closely monitor side effects to find the best dose for the combination.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CASTRATION-RESISTANT PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
OHSU Knight Cancer Institute
Portland, Oregon, 97239, United States
-
Portland VA Medical Center
Portland, Oregon, 97239, United States
-
Seattle Cancer Care Alliance
Seattle, Washington, 98109, United States
Conditions
Explore the condition pages connected to this study.